Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingosine 1-phosphate receptor subtype 5 (S1PR5) is a G protein-coupled receptor (GPCR) that binds the bioactive lipid sphingosine-1-phosphate (S1P). It plays a critical role in regulating T cell trafficking, particularly influencing the infiltration and emigration of T cells from peripheral organs and is involved in innate lymphoid cell development and NK cell trafficking. It is also a potential therapeutic target for neurodegenerative and demyelinating diseases by supporting oligodendrocyte function and myelination, and in cancer by influencing tumor growth and metastasis.
Agonists or antagonists modulate S1PR5-mediated signaling pathways, influencing immune cell trafficking, oligodendrocyte function, and tumor growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sphingosine 1-phosphate receptor subtype 5 (S1PR5).